Detalhe da pesquisa
1.
Dynamic Risk Profiling Using Serial Tumor Biomarkers for Personalized Outcome Prediction.
Cell
; 178(3): 699-713.e19, 2019 07 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-31280963
2.
Decitabine in Older Patients with AML: Quality of Life Results of the EORTC-GIMEMA-GMDS-SG Randomized Phase III Trial.
Blood
; 2024 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38717861
3.
Vemurafenib plus Rituximab in Refractory or Relapsed Hairy-Cell Leukemia.
N Engl J Med
; 384(19): 1810-1823, 2021 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33979489
4.
Genetic and phenotypic attributes of splenic marginal zone lymphoma.
Blood
; 139(5): 732-747, 2022 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34653238
5.
Tafasitamab for patients with relapsed or refractory diffuse large B-cell lymphoma: final 5-year efficacy and safety findings in the phase II L-MIND study.
Haematologica
; 109(2): 553-566, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37646664
6.
Patients' preferences for chronic lymphocytic leukemia treatment: The CHOICE study.
Hematol Oncol
; 42(1): e3216, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37772620
7.
Genetic mechanisms of HLA-I loss and immune escape in diffuse large B cell lymphoma.
Proc Natl Acad Sci U S A
; 118(22)2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34050029
8.
Targeting BTK in B Cell Malignancies: From Mode of Action to Resistance Mechanisms.
Int J Mol Sci
; 25(6)2024 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38542207
9.
SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry.
Lancet Oncol
; 24(4): 335-346, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36898391
10.
XPO1 mutations identify early-stage CLL characterized by shorter time to first treatment and enhanced BCR signalling.
Br J Haematol
; 203(3): 416-425, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37580908
11.
Dose/schedule-adjusted Rd-R vs continuous Rd for elderly, intermediate-fit patients with newly diagnosed multiple myeloma.
Blood
; 137(22): 3027-3036, 2021 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33739404
12.
Preexisting and treatment-emergent autoimmune cytopenias in patients with CLL treated with targeted drugs.
Blood
; 137(25): 3507-3517, 2021 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33651883
13.
Active Akt signaling triggers CLL toward Richter transformation via overactivation of Notch1.
Blood
; 137(5): 646-660, 2021 02 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33538798
14.
Results from a phase I/II trial of cusatuzumab combined with azacitidine in patients with newly diagnosed acute myeloid leukemia who are ineligible for intensive chemotherapy.
Haematologica
; 108(7): 1793-1802, 2023 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36779592
15.
The immunomodulatory molecule TIGIT is expressed by chronic lymphocytic leukemia cells and contributes to anergy.
Haematologica
; 108(8): 2101-2115, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36655432
16.
Treatment Refractoriness in Chronic Lymphocytic Leukemia: Old and New Molecular Biomarkers.
Int J Mol Sci
; 24(12)2023 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37373521
17.
Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study.
Lancet Oncol
; 23(7): 865-875, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35660139
18.
Donor-derived acute myeloid leukemia in solid organ transplantation.
Am J Transplant
; 22(12): 3111-3119, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35979657
19.
Inducible T-cell co-stimulator (ICOS) and ICOS ligand are novel players in the multiple-myeloma microenvironment.
Br J Haematol
; 196(6): 1369-1380, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34954822
20.
Prognostic impact of TP53 mutation in newly diagnosed diffuse large B-cell lymphoma patients treated in the FIL-DLCL04 trial.
Br J Haematol
; 196(5): 1184-1193, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34951009